Far Point Acquisition Corporation Files for $400 Million $500 Million IPO
Far Point Acquisition Corp, the Third Point LLC sponsored Fintech SPAC, filed an amended S-1 today, upsizing the deal to $500 million. Previous filings indicated an IPO of $400 million.
Upsizing an IPO 25% signals a tremendous amount of demand already, although this is unsurprising given the high profile nature of this SPAC. Far Point should price next week, right behind GS Acquisition Holdings Corp. Below is a reminder of Far Point’s summary terms.
Summary terms include:
- $10.00 unit comprised of one share of Class A common Stock and one-third of a full warrant
- 100% held in trust ($10.00 per share)
- 24 months to announce an acquisition (+ 3 month extension with LOI)
- Warrant Redemption Price: $18.00
- Redemption Rights: limitation of 15% of the shares sold in the IPO
- Sponsored by Far Point LLC, an affiliate of Third Point LLC
- Forward Purchase Agreement: capped at the amount of redeeming shares over 20 million (40% of the IPO)
- Underwriter fees: 2.0% + 3.5% deferred fee
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...